Oncotarget recently published "PD-1/PD-L1 expression in anal squamous intraepithelial lesions" which reported that the presence and distribution of CD8 lymphocytes and the presence of PD-1 lymphocytes ...

Ruxolitinib (a JAK2 inhibitor) and belumosudil (a ROCK2 inhibitor) have recently been approved by the Food and Drug Administration (FDA) for the treatment of chronic graft-versus-host disease (GVHD).

A benign esophageal cell papilloma is a small, noncancerous tumor that forms in the esophagus. Most do not cause symptoms. Doctors treat the growth by removing it. A papilloma is a benign ...

Penile squamous cell carcinoma (PSCC) is a rare but aggressive malignancy that severely affects men’s health worldwide.

Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free ...